Jump to Main Content

Highlights of ASH®

Highlights of ASH in North America


About Highlights of ASH in North America

By attending Highlights of ASH, you will gain a comprehensive understanding of significant scientific updates in clinical and translational hematologic research, learn how these updates directly affect the study and practice of hematology, and discover how new research can be translated into cutting-edge patient care.

Throughout this meeting, you will be able to:

Blood icon

Explore a program that covers the latest and most influential topics in hematology curated from the premier science presented at the ASH annual meeting.

icon for engage interaction-an avatar looking at the screen

Actively engage in interactive panel discussions with speakers and attend small group lunch sessions with experts in the field.

An icon for a group of experts

Network with speakers, exhibitors, and peers in a close-knit setting.

A calendar icon for scheduling events

Connect with a community of individuals who share common goals and hold a mutual appreciation for the scientific advancements.

View Program Information


Program Schedule

The program schedule below is identical for all 2026 Highlights of ASH in North America locations. The following information is preliminary and subject to change.

11:00 a.m. Registration and Exhibits Open (Lunch provided)
11:45 p.m. Welcome and Introductions
12:00 p.m. Plasma Cell Disorders
Noura Elsedawy, MBBCh 
University of Tennessee Health Science Center
New York, NY
Washington, DC
Craig Hofmeister, MD, MPH
Emory University  
Seattle, WA 
Ruben Niesvizky, MD 
Weill Cornell Medicine  
Chicago, IL 
12:45 p.m. Transplant 
Alexandra Gomez Arteaga, MD
Weill Cornell Medicine, New York Presbyterian Hospital 
New York, NY 
Marcos de Lima, MD 
The Ohio State University  
Seattle, WA
Mark Levis, MD, PhD 
Johns Hopkins University    
Washington, DC  
Mariam Nawas, MD
University of Chicago Medical Center
 
Chicago, IL 
1:30 p.m. Pediatric Hematologic Malignancies 
Rebecca Gardner, MD 
St. Jude Children’s Research Hospital
Chicago, IL 
Rachel Rau, MD 
University of Washington 
Seattle, WA
Rayne H. Rouce, MD 
Baylor College of Medicine  
New York, NY 
Washington, DC 
2:15 p.m. Panel Discussion
2:45 p.m. Coffee Break and Exhibits Open
3:00 p.m. Aggressive Lymphoma 
Manali Kamdar, MD, MBBS 
University of Colorado
Seattle, WA
John Kuruvilla, MD, FRCPC 
Princess Margaret Cancer Centre  
New York, NY 
Selay Lam, MD 
Western University, London Health Sciences Centre  
Chicago, IL  
Craig Moskowitz, MD
University of Miami, Sylvester Comprehensive Cancer Center
 
Washington, DC  
3:45 p.m. Acute Lymphoblastic Leukemia

Emily Curran, MD 
University of Cincinnati Cancer Center 

New York, NY 
Rawan Faramand, MD 
H. Lee Moffitt Cancer Center
Washington, DC  
John Molina, MD, EdM 
Taussig Cancer Institute, Cleveland Clinic
Seattle, WA
Lori Muffly, MD, MS 
Stanford University  
Chicago, IL  
4:30 p.m. Indolent Lymphoma and Chronic Lymphocytic Leukemia 
Jia Ruan, MD, PhD
Weill Cornell Medicine 
New York, NY 
Mazyar Shadman, MD, MPH 
Fred Hutchinson Cancer Center, University of Washington
Chicago, IL 
Seattle, WA
Tanya Siddiqi, MD 
City of Hope Orange County
Washington, DC 
5:15 p.m. Panel Discussion
5:45 p.m.  Highlights of ASH Day 1 Program Adjournment 
7:00 a.m. Registration and Exhibits Open
(Breakfast provided)
7:45 a.m. Welcome and Introductions
8:00 a.m.

Bleeding Disorders

Tyler W. Buckner, MD, MSc
University of Colorado School of Medicine

Washington, DC

Peter H. Cygan, MD
Penn State Health Milton S. Hershey Medical Center
New York, NY
Kristina Maria Haley, DO
Oregon Health & Science University
Seattle, WA 
Lynn Malec, MD, MSc
Versiti Blood Research Institute, Medical College of Wisconsin 
Chicago, IL 
8:45 a.m.

Thrombosis

Joana M. Mack, MD
Arkansas Children's Hospital, University of Arkansas for Medical Sciences

Washington, DC 

Anna L. Parks, MD
University of Utah
Seattle, WA
Rachel P. Rosovsky, MD, MPH
Massachusetts General Hospital, Harvard Medical School
New York, NY
Robert Stern, MD, EdM 
Brigham and Women’s Hospital 
Chicago, IL 
9:30 a.m.

Women's Health

Imo J. Akpan, MD
Columbia University Irving Medical Center
New York, NY 
Allison P. Wheeler, MD, MSCI
University of Washington
Chicago, IL 
Seattle, WA
Meera Chitlur, MD
Central Michigan University, Children's Hospital of Michigan
 
Washington, DC 
10:15 a.m. Panel Discussion 
10:45 a.m. Coffee Break and Exhibits Open
11:00 a.m.

Myelodysplastic Syndromes, Myeloproliferative Neoplasms, & Chronic Myeloid Leukemia

Uma Borate, MD, MS
The Ohio State University

Chicago, IL

Akriti Gupta Jain, MD, FACP
Cleveland Clinic
New York, NY
Seattle, WA

Brandi Reeves, MD
University of North Carolina at Chapel Hill

Washington, DC

11:45 a.m.

Acute Myeloid Leukemia

Jessica K. Altman, MD
Northwestern Medicine

New York, NY

David Sanford, MD
UBC-BC Cancer Agency, Vancouver Coastal Health
Seattle, WA 
Caner Saygin, MD
University of Chicago

Chicago, IL 

Eunice S. Wang, MD
Roswell Park Comprehensive Cancer Center

Washington, DC 
12:30 p.m. Panel Discussion
1:00 p.m. Lunch with the Experts
(All Speakers and Attendees)
2:15 p.m. Hemoglobinopathies & Red Blood Cell Disorders

Oyebimpe O. Adesina, MD, MS
University of California Davis School of Medicine

Seattle, WA

Payal Desai, MD
Levine Cancer Institute, Atrium Health, Wake Forest University

New York, NY

India Sisler, MD
Children’s Hospital of Richmond at VCU
Washington, DC
Madhav Vissa, MD
UCSF Benioff Children’s Hospital
Chicago, IL
3:00 p.m.

Immune Cytopenias

Juliana P. Botero, MD, MS
Mayo Clinic

New York, NY

Cyrus C. Hsia, MD, FRCPC
Western University, London Health Sciences Center
Washington, DC

Caroline Piatek, MD
University of Southern California

Seattle, WA

Senthil Sukumar, MD, MS
Baylor College of Medicine
Chicago, IL
3:45 p.m.

Artificial Intelligence & Informatics in Hematology Practice Improvement

Benjamin Chin-Yee, MD, MA, FRCPC
Western University

Chicago, IL

Barbara Lam, MD
Fred Hutchinson Cancer Center, University of Washington

Seattle, WA

Ang Li, MD, MS
Baylor College of Medicine

New York, NY

Rushad Patell, MD
Beth Isreal Deaconess Medical Center
Washington, DC
4:30 p.m. Panel Discussion
5:00 p.m. Closing Remarks and Adjournment

Acknowledgements

Thank you to our esteemed committee of experts dedicated to advancing the development of this meeting, and our company partners for providing educational grants in support of the 2026 Highlights of ASH in North America

  • Jia Ruan, MD, PhD, Chair, Weill Cornell Medicine 
  • Tyler Buckner, MD, MSc, University of Colorado Denver 
  • Payal C. Desai, MD, Atrium Health
  • Cyrus C. Hsia, MD, BSc, FRCPC, Western University
  • Manali Kamdar, MD, University of Colorado
  • Ang Li, MD, MS, Baylor College of Medicine
  • John C. Molina, MD, MEd, Cleveland Clinic
  • Ruben Niesvizky, MD, Weill Cornell Medicine
  • Rachel P. Rosovsky, MD, Harvard Medical School
  • Rayne H. Rouce, MD, Baylor College of Medicine
  • Eric Tse, MBBS, PhD, Hong Kong University